Background Deoxyspergualin (DSG), a potent immunosuppressive drug, has been
clinically used as a rescue therapy for acute graft rejection. However, DS
G has severe adverse effects that limits its use. Here, we examined the opt
imized therapeutic protocol for DSG using chronopharmacological profiles of
it.
Methods. First, a dosing time-dependent difference in the toxicity and effi
cacy of DSG was determined using a heterotopic heart transplantation model.
Second, chronokinetics of DSG were examined to reveal the mechanism for do
sing time-dependent differences in the effect.
Results. In rats treated with DSG at the active period, bone marrow suppres
sion and damage of small intestine were significantly severe. However, no s
ignificant difference was found in cardiac allograft survival and pharmacok
inetics according to the timing of drug administration.
Conclusions. The toxicity of DSG varied with the dosing time, whereas its e
fficacy did not. The chronopharmacological approach may provide merits for
immunosuppressive therapy with DSG in clinical organ transplantation.